These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 18474596

  • 1. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
    Lee AM, Rojek JM, Spiropoulou CF, Gundersen AT, Jin W, Shaginian A, York J, Nunberg JH, Boger DL, Oldstone MB, Kunz S.
    J Biol Chem; 2008 Jul 04; 283(27):18734-42. PubMed ID: 18474596
    [Abstract] [Full Text] [Related]

  • 2. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G, Trofimenko E, Mayor J, Fedeli C, Moreno H, Michel S, Heulot M, Chevalier N, Zimmer G, Shrestha N, Plattet P, Engler O, Rothenberger S, Widmann C, Kunz S.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30626681
    [Abstract] [Full Text] [Related]

  • 3. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.
    Radoshitzky SR, Kuhn JH, de Kok-Mercado F, Jahrling PB, Bavari S.
    Expert Opin Drug Discov; 2012 Jul 15; 7(7):613-32. PubMed ID: 22607481
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.
    Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, Bleam M, Hruby DE.
    Antiviral Res; 2006 Feb 15; 69(2):86-97. PubMed ID: 16343651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.
    Thomas CJ, Casquilho-Gray HE, York J, DeCamp DL, Dai D, Petrilli EB, Boger DL, Slayden RA, Amberg SM, Sprang SR, Nunberg JH.
    J Biol Chem; 2011 Feb 25; 286(8):6192-200. PubMed ID: 21159779
    [Abstract] [Full Text] [Related]

  • 7. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
    Gowen BB, Naik S, Westover JB, Brown ER, Gantla VR, Fetsko A, Dagley AL, Blotter DJ, Anderson N, McCormack K, Henkel G.
    Antiviral Res; 2021 Sep 25; 193():105125. PubMed ID: 34197863
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Arenaviruses other than Lassa virus.
    Charrel RN, de Lamballerie X.
    Antiviral Res; 2003 Jan 25; 57(1-2):89-100. PubMed ID: 12615305
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism.
    Spence JS, Melnik LI, Badani H, Wimley WC, Garry RF.
    J Virol; 2014 Aug 25; 88(15):8556-64. PubMed ID: 24850726
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.
    Herring S, Oda JM, Wagoner J, Kirchmeier D, O'Connor A, Nelson EA, Huang Q, Liang Y, DeWald LE, Johansen LM, Glass PJ, Olinger GG, Ianevski A, Aittokallio T, Paine MF, Fink SL, White JM, Polyak SJ.
    Antimicrob Agents Chemother; 2021 Mar 18; 65(4):. PubMed ID: 33468464
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Arenavirus research and antiviral candidate].
    Tani H, Shuzo U.
    Uirusu; 2018 Mar 18; 68(1):51-62. PubMed ID: 31105135
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.